Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression

Urology

Volumn 59, Issue 1, 2002, Pages 97-102

  Grossfeld, Gary D ^a,b   Carroll, Peter R ^a,b   Lindeman, Neil ^a   Meng, Maxwell ^a   Groshen, Susan ^c   Feng, An Chen ^c   Hawes, Debra ^c   Cote, Richard J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; THROMBOSPONDIN 1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; SEMINAL VESICLE; TUMOR GROWTH;

ADENOCARCINOMA; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036144454     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01476-5     Document Type: Article

References (30)

1. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer; a multi-institutional update
2. Seminars in medicine of the Beth Israel Hospital, Boston; clinical applications of research on angiogenesis
3. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
4. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma; a quantitative histologic study
5. Angiogenesis in bladder cancer; relationship between microvessel density and tumor prognosis
6. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
7. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate
8. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer
9. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy
10. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
11. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate; lack of significance for microvessel density analysis
12. Role of microvessel density in predicting recurrence in pathologic stage T3 prostatic adenocarcinoma
13. Microvessel density in prostate cancer; lack of correlation with tumor grade, pathologic stage, and clinical outcome
14. Thrombospondin-1 expression in bladder cancer; association with p53 alterations, tumor angiogenesis, and tumor progression
15. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro
16. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
17. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
18. Accumulation of nuclear p53 and tumor progression in bladder cancer
19. Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity
20. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma
21. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
22. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy
23. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
24. p53 protein and gene alterations in pathological stage C prostate carcinoma
25. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma
26. Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma
27. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas
28. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma
29. Independent association of angiogenesis index with outcome in prostate cancer